IN delivery provides a sustained, lower-level exposure over 8 weeks
What forms the bulk of the retail price2 of peptides is not the cost of manufacturing, but the capital infrastructure: the regulatory burden, the cold chain logistics, the pen device (which sometimes costs more than the drug itself), and, above all, the return needed to justify $9 billion in the initial R&D of these GLP-1 drugs
Staying vigilant and informed empowers you to maximize the benefits of your regimen, ensuring youre not just managing your condition but thriving.
Vleminckx S, Virgilio N, Asserin J, Prawitt J, Silva CIF
It is about precision, personalization, and longevity
Retatrutide's approximately 6-day half-life directly supports a once-weekly subcutaneous injection regimen, maintaining relatively stable plasma drug levels between doses and mirroring the dosing schedules of other long-acting incretin-based therapies such as semaglutide and tirzepatide